242 related articles for article (PubMed ID: 38778365)
1. Reporting on patient's body mass index (BMI) in recent clinical trials for patients with breast cancer: a systematic review.
Van Cauwenberge J; Van Baelen K; Maetens M; Geukens T; Nguyen HL; Nevelsteen I; Smeets A; Deblander A; Neven P; Koolen S; Wildiers H; Punie K; Desmedt C
Breast Cancer Res; 2024 May; 26(1):81. PubMed ID: 38778365
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Recurrence dynamics of breast cancer according to baseline body mass index.
Biganzoli E; Desmedt C; Fornili M; de Azambuja E; Cornez N; Ries F; Closon-Dejardin MT; Kerger J; Focan C; Di Leo A; Nogaret JM; Sotiriou C; Piccart M; Demicheli R
Eur J Cancer; 2017 Dec; 87():10-20. PubMed ID: 29096156
[TBL] [Abstract][Full Text] [Related]
4. Body weight management in overweight and obese breast cancer survivors.
Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
[TBL] [Abstract][Full Text] [Related]
5. The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).
Morrison VA; McCall L; Muss HB; Jatoi A; Cohen HJ; Cirrincione CT; Ligibel JA; Lafky JM; Hurria A
J Geriatr Oncol; 2018 May; 9(3):228-234. PubMed ID: 29233548
[TBL] [Abstract][Full Text] [Related]
6. Hormonal contraceptives for contraception in overweight or obese women.
Lopez LM; Bernholc A; Chen M; Grey TW; Otterness C; Westhoff C; Edelman A; Helmerhorst FM
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008452. PubMed ID: 27537097
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
[TBL] [Abstract][Full Text] [Related]
8. Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(22):1-23. PubMed ID: 23074527
[TBL] [Abstract][Full Text] [Related]
9. Early breast cancer: why does obesity affect prognosis?
Heetun A; Cutress RI; Copson ER
Proc Nutr Soc; 2018 Nov; 77(4):369-381. PubMed ID: 29860965
[TBL] [Abstract][Full Text] [Related]
10. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.
Mead E; Brown T; Rees K; Azevedo LB; Whittaker V; Jones D; Olajide J; Mainardi GM; Corpeleijn E; O'Malley C; Beardsmore E; Al-Khudairy L; Baur L; Metzendorf MI; Demaio A; Ells LJ
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012651. PubMed ID: 28639319
[TBL] [Abstract][Full Text] [Related]
11. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.
Ara R; Blake L; Gray L; Hernández M; Crowther M; Dunkley A; Warren F; Jackson R; Rees A; Stevenson M; Abrams K; Cooper N; Davies M; Khunti K; Sutton A
Health Technol Assess; 2012; 16(5):iii-xiv, 1-195. PubMed ID: 22340890
[TBL] [Abstract][Full Text] [Related]
12. Obesity in breast cancer--what is the risk factor?
James FR; Wootton S; Jackson A; Wiseman M; Copson ER; Cutress RI
Eur J Cancer; 2015 Apr; 51(6):705-20. PubMed ID: 25747851
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab-containing regimens for metastatic breast cancer.
Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
[TBL] [Abstract][Full Text] [Related]
14. Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy.
Takada K; Kashiwagi S; Asano Y; Goto W; Ishihara S; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
BMC Cancer; 2021 Oct; 21(1):1129. PubMed ID: 34670511
[TBL] [Abstract][Full Text] [Related]
15. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
16. Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
Raman R; Mott SL; Schroeder MC; Phadke S; El Masri J; Thomas A
Clin Breast Cancer; 2016 Dec; 16(6):480-486. PubMed ID: 27431461
[TBL] [Abstract][Full Text] [Related]
17. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
